港股異動 | 海吉亞醫療(6078.HK)大漲11%續創歷史新高 上市迄今已累漲超2.2倍
格隆匯9月14日丨海吉亞醫療(6078.HK)高開高走,盤中高見59.5港元再創歷史新高,現報59.35港元,大漲11.04%,暫成交3419萬港元,最新總市值356億港元。該股自今年6月29日於港交所上市迄今,僅2個半月時間較發行價18.5港元已累漲超2.2倍。此外,海吉亞醫療獲納入深港通下的港股通股票名單,自9月7日起生效。據港交所最新數據顯示,截至9月9日,港股通資金持有該股的比例為2.18%;自納入港股通以來,該股從46.6港元上漲至今累漲超27%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.